These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling. Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099 [TBL] [Abstract][Full Text] [Related]
5. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy. Winters-Stone KM; Horak F; Jacobs PG; Trubowitz P; Dieckmann NF; Stoyles S; Faithfull S J Clin Oncol; 2017 Aug; 35(23):2604-2612. PubMed ID: 28586243 [TBL] [Abstract][Full Text] [Related]
11. The psychometric properties of the Turkish version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT). Kutlutürkan S; Öztürk ES; Arıkan F; Kahraman BB; Özcan K; Uçar MA Eur J Oncol Nurs; 2017 Dec; 31():84-89. PubMed ID: 29173832 [TBL] [Abstract][Full Text] [Related]
12. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer. Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582 [TBL] [Abstract][Full Text] [Related]
13. Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy. Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CS; Kiernan MC; Park SB Muscle Nerve; 2018 Apr; 57(4):615-621. PubMed ID: 28881477 [TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments. Kiser DW; Greer TB; Wilmoth MC; Dmochowski J; Naumann RW Oncol Nurs Forum; 2010 Nov; 37(6):758-64. PubMed ID: 21059587 [TBL] [Abstract][Full Text] [Related]
16. Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer. Postma TJ; Hoekman K; van Riel JM; Heimans JJ; Vermorken JB J Neurooncol; 1999; 45(3):241-6. PubMed ID: 10845395 [TBL] [Abstract][Full Text] [Related]
17. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy. Stubblefield MD; McNeely ML; Alfano CM; Mayer DK Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699 [TBL] [Abstract][Full Text] [Related]
18. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466 [TBL] [Abstract][Full Text] [Related]
19. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy. Amara S Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011 [TBL] [Abstract][Full Text] [Related]